Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Knight Therapeutics | 1 | 0 | 0 | 0 | €3.88 | €10.00 | 157.732% |
| AstraZeneca plc | 1 | 0 | 0 | 0 | €139.90 | €165.00 | 17.941% |
| Clinuvel Pharmaceuticals | 1 | 0 | 0 | 0 | €9.11 | - | - |
| GSK plc | 1 | 0 | 0 | 0 | €20.18 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €346.50 | - | - |
| Vivoryon Therapeutics N.V. | 1 | 0 | 0 | 0 | €0.76 | - | - |
| Fagron N.V. | 1 | 0 | 0 | 0 | €18.34 | €20.00 | 9.051% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.92 | - | - |
| Blueprint Medicines Corp | 1 | 0 | 1 | 0 | €99.62 | - | - |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €128.00 | €150.00 | 17.188% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.37 | - | - |
| Cosmo Pharmaceuticals S.A. | 1 | 0 | 0 | 0 | €73.00 | - | - |
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €123.20 | €130.00 | 5.519% |
| Novartis AG ADR | 1 | 0 | 0 | 0 | €91.00 | - | - |
| Faes Farma S.A. | 1 | 0 | 0 | 0 | €3.45 | €6.00 | 73.913% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Enanta Pharmaceuticals Inc. | 5 | 4 | 0 | 1 | €12.70 | €26.92 | 111.996% |
| Laboratorios Farmaceuticos | 1 | 0 | 0 | 0 | €82.45 | €100.00 | 21.286% |
| Lisata Therapeutics Inc. | 1 | 0 | 0 | 0 | €2.42 | €4.00 | 65.289% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €43.60 | - | - |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €115.40 | €109.00 | -5.546% |
| Compugen Ltd. | 2 | 2 | 0 | 0 | €2.01 | €3.67 | 82.813% |
| Emergent Biosolutions Inc. | 2 | 3 | 1 | 1 | €3.62 | €4.62 | 27.647% |
| Cellectar BioSciences Inc. | 7 | 8 | 0 | 0 | €3.20 | €10.55 | 229.556% |